Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism AHR modulators(Aryl hydrocarbon receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Keratoacanthoma | Discovery | - | 18 Apr 2024 | |
Myelodysplastic Syndromes | Discovery | - | 18 Apr 2024 | |
Myelofibrosis | Discovery | - | 18 Apr 2024 | |
Neoplasms | Discovery | - | 18 Apr 2024 | |
Peritoneal Diseases | Discovery | - | 18 Apr 2024 | |
Prostatic Hyperplasia | Discovery | - | 18 Apr 2024 | |
Psoriasis | Discovery | - | 18 Apr 2024 |